BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 14626695)

  • 1. Recent developments in the neuropathological diagnosis of Parkinson's disease and parkinsonism.
    Michotte A
    Acta Neurol Belg; 2003 Sep; 103(3):155-8. PubMed ID: 14626695
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phosphorylated Smad 2/3 colocalizes with phospho-tau inclusions in Pick disease, progressive supranuclear palsy, and corticobasal degeneration but not with alpha-synuclein inclusions in multiple system atrophy or dementia with Lewy bodies.
    Chalmers KA; Love S
    J Neuropathol Exp Neurol; 2007 Nov; 66(11):1019-26. PubMed ID: 17984683
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Diagnostic criteria of parkinsonian syndromes].
    Tison F
    Rev Neurol (Paris); 2003 May; 159(5 Pt 2):3S19-23. PubMed ID: 12773884
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Neuropathology of tauopathies and synucleinopathies, and neuroanatomy of sleep disorders: meeting the challenge].
    Hauw JJ; Hausser-Hauw C; Duyckaerts C
    Rev Neurol (Paris); 2003 Nov; 159(11 Suppl):6S59-70. PubMed ID: 14646802
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An overview of parkinsonian syndromes: data from the literature and from an Italian data-base.
    Pezzoli G; Canesi M; Galli C
    Sleep Med; 2004 Mar; 5(2):181-7. PubMed ID: 15033141
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Parkinson's syndrome associated with neurofibrillary degeneration and tau pathologic findings.
    Lees AJ
    Mov Disord; 2003 Sep; 18 Suppl 6():S28-33. PubMed ID: 14502653
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Atypical parkinsonism].
    Tysnes OB; Vilming ST
    Tidsskr Nor Laegeforen; 2008 Sep; 128(18):2077-80. PubMed ID: 18846125
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anatamopathological spectrum of tauopathies.
    Revesz T; Holton JL
    Mov Disord; 2003 Sep; 18 Suppl 6():S13-20. PubMed ID: 14502651
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical and neuropathological correlates of Lewy body disease.
    Hishikawa N; Hashizume Y; Yoshida M; Sobue G
    Acta Neuropathol; 2003 Apr; 105(4):341-50. PubMed ID: 12624787
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Parkinsonism plus syndrome--a review.
    Mitra K; Gangopadhaya PK; Das SK
    Neurol India; 2003 Jun; 51(2):183-8. PubMed ID: 14570999
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A differential diagnosis of Parkinsonism.
    Weiner WJ
    Rev Neurol Dis; 2005; 2(3):124-31. PubMed ID: 16400311
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical diagnostic criteria in Parkinson's disease and parkinsonian syndromes: review of the literature].
    Vercueil L
    Rev Neurol (Paris); 2000; 156 Suppl 2 Pt 2():14-22. PubMed ID: 10916032
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Frontotemporal lobar degeneration and dementia with Lewy bodies: clinicopathological issues associated with antemortem diagnosis.
    Yokota O
    Psychogeriatrics; 2009 Jun; 9(2):91-102. PubMed ID: 19604332
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparison of degeneration in motor thalamus and cortex between progressive supranuclear palsy and Parkinson's disease.
    Halliday GM; Macdonald V; Henderson JM
    Brain; 2005 Oct; 128(Pt 10):2272-80. PubMed ID: 16014651
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Study of the pre and post-synaptic dopaminergic system by DaTSCAN/IBZM SPECT in the differential diagnosis of parkinsonism in 75 patients].
    Vaamonde J; Ibáñez R; García AM; Poblete V
    Neurologia; 2004; 19(6):292-300. PubMed ID: 15199417
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical correlates of the pathology underlying parkinsonism: a population perspective.
    Bower JH; Dickson DW; Taylor L; Maraganore DM; Rocca WA
    Mov Disord; 2002 Sep; 17(5):910-6. PubMed ID: 12360539
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interface between tauopathies and synucleinopathies: a tale of two proteins.
    Galpern WR; Lang AE
    Ann Neurol; 2006 Mar; 59(3):449-58. PubMed ID: 16489609
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MRI for the differential diagnosis of neurodegenerative parkinsonism in clinical practice.
    Seppi K
    Parkinsonism Relat Disord; 2007; 13 Suppl 3():S400-5. PubMed ID: 18267272
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Brain magnetic resonance imaging techniques in the diagnosis of parkinsonian syndromes.
    Seppi K; Poewe W
    Neuroimaging Clin N Am; 2010 Feb; 20(1):29-55. PubMed ID: 19959017
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Atypical protein kinase C in neurodegenerative disease II: PKCiota/lambda in tauopathies and alpha-synucleinopathies.
    Shao CY; Crary JF; Rao C; Sacktor TC; Mirra SS
    J Neuropathol Exp Neurol; 2006 Apr; 65(4):327-35. PubMed ID: 16691114
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.